These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine. Bröker M; Veitch K Travel Med Infect Dis; 2010 Jan; 8(1):47-50. PubMed ID: 20188306 [TBL] [Abstract][Full Text] [Related]
4. Meningococcal disease: risk for international travellers and vaccine strategies. Wilder-Smith A Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105 [TBL] [Abstract][Full Text] [Related]
6. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Poland GA Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016 [TBL] [Abstract][Full Text] [Related]
7. The epidemiology of meningococcal disease and the impact of vaccines. Khatami A; Pollard AJ Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857 [TBL] [Abstract][Full Text] [Related]
8. [Group B meningococcal invasive infections: an unresolved public health problem]. Crisinel PA; Posfay-Barbe KM Rev Med Suisse; 2011 Feb; 7(283):447-50. PubMed ID: 21452513 [TBL] [Abstract][Full Text] [Related]
9. [Vaccinal strategies in response to new epidemiological challenges in 2010. Reasonable hope for a "B" meningococcal vaccine]. Nicolas P Med Trop (Mars); 2010 Aug; 70(4):325-32. PubMed ID: 22368926 [TBL] [Abstract][Full Text] [Related]
10. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease. Zuckerman JN; Bröker M; Worth C Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511 [TBL] [Abstract][Full Text] [Related]
12. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. Trotter CL; Ramsay ME FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998 [TBL] [Abstract][Full Text] [Related]
13. Challenges for development of meningococcal vaccines in infants and children. Deasy A; Read RC Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project. Soriano-Gabarró M; Rosenstein N; LaForce FM J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780 [TBL] [Abstract][Full Text] [Related]
15. Meningococcal vaccine against serogroups A, C, Y and W-135: new preparation. Encouraging immunogenicity studies. Prescrire Int; 2002 Apr; 11(58):35-8. PubMed ID: 11987309 [TBL] [Abstract][Full Text] [Related]
16. Meningococcal disease. Memish ZA; Alrajhi AA Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412 [TBL] [Abstract][Full Text] [Related]